Review



ire1i  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    MedChemExpress ire1i
    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor <t>(IRE1i)</t> 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Ire1i, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 97 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ire1i/4%CE%BC8C/pmc12810646-220-29-34
    Average 95 stars, based on 97 article reviews
    ire1i - by Bioz Stars, 2026-09
    95/100 stars

    Images

    1) Product Images from "Enterococcus faecalis redox metabolism activates the unfolded protein response to impair wound healing"

    Article Title: Enterococcus faecalis redox metabolism activates the unfolded protein response to impair wound healing

    Journal: Science Advances

    doi: 10.1126/sciadv.aeb5297

    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor (IRE1i) 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Figure Legend Snippet: ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor (IRE1i) 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).

    Techniques Used: Gene Expression, Infection, Western Blot, Scratch Wound Assay Assay, Positive Control, Control

    ( A ) E. faecalis OG1RF Tn screen in which a library of 14,976 mutants was screened against an NIH-3T3 cell line expressing the Xbp1-mApple reporter system (3T3R). ( B ) Representative epifluorescence microscopy images of 3T3R under different conditions (uninfected, WT, and Tm-treated) at 21 hpi. Scale bar, 100 μm. ( C ) Diagram showing the pathways in which a subset of UPR-defective mutants (genes/proteins with red font) were identified. DHNA, 1,4-dihydroxy-2-naphthoic acid; GPP, geranyl diphosphate; HPP, heptaprenyl diphosphate; ETC, electron transport chain. ( D ) Validation of UPR-defective mutants with 3T3R ( n = 3). ( E ) UPR induction by WT and ΔT7SS in a 3T3(R) background ( n = 3). ( F and G ) Scratch wound assay quantification for HaCaT infected with (F) WT and ΔEET, which were also (G) treated with either 0.5% DMSO control (open circles) or IRE1i (close circles). WT data are identical to and replicated here for ease of comparison ( n = 4 biological replicates). The data underlying and (F) and (G) were generated in the same experimental sets and can therefore be directly compared against each other. Shaded areas represent 1 SD for each condition. ( H ) UPR induction at 24 hpi in HaCaT after treatment with 0.5% DMSO control (open circles) or IRE1i (closed circles) under uninfected, WT-infected, and ΔEET-infected conditions. Uninfected and WT-infected findings are identical to and replicated here for ease of comparison ( n = 3). Significance was determined using one-way ANOVA Dunnett’s test [(D) and (E)], two-way ANOVA Tukey’s test [(F) and (G)], or one-way ANOVA Tukey’s test (H) (*** P < 0 0.001 and **** P < 0.0001).
    Figure Legend Snippet: ( A ) E. faecalis OG1RF Tn screen in which a library of 14,976 mutants was screened against an NIH-3T3 cell line expressing the Xbp1-mApple reporter system (3T3R). ( B ) Representative epifluorescence microscopy images of 3T3R under different conditions (uninfected, WT, and Tm-treated) at 21 hpi. Scale bar, 100 μm. ( C ) Diagram showing the pathways in which a subset of UPR-defective mutants (genes/proteins with red font) were identified. DHNA, 1,4-dihydroxy-2-naphthoic acid; GPP, geranyl diphosphate; HPP, heptaprenyl diphosphate; ETC, electron transport chain. ( D ) Validation of UPR-defective mutants with 3T3R ( n = 3). ( E ) UPR induction by WT and ΔT7SS in a 3T3(R) background ( n = 3). ( F and G ) Scratch wound assay quantification for HaCaT infected with (F) WT and ΔEET, which were also (G) treated with either 0.5% DMSO control (open circles) or IRE1i (close circles). WT data are identical to and replicated here for ease of comparison ( n = 4 biological replicates). The data underlying and (F) and (G) were generated in the same experimental sets and can therefore be directly compared against each other. Shaded areas represent 1 SD for each condition. ( H ) UPR induction at 24 hpi in HaCaT after treatment with 0.5% DMSO control (open circles) or IRE1i (closed circles) under uninfected, WT-infected, and ΔEET-infected conditions. Uninfected and WT-infected findings are identical to and replicated here for ease of comparison ( n = 3). Significance was determined using one-way ANOVA Dunnett’s test [(D) and (E)], two-way ANOVA Tukey’s test [(F) and (G)], or one-way ANOVA Tukey’s test (H) (*** P < 0 0.001 and **** P < 0.0001).

    Techniques Used: Expressing, Epifluorescence Microscopy, Biomarker Discovery, Scratch Wound Assay Assay, Infection, Control, Comparison, Generated

    Related Articles

    Real-time Polymerase Chain Reaction:

    Article Title: Enterococcus faecalis redox metabolism activates the unfolded protein response to impair wound healing
    Article Snippet: .. Unless otherwise specified, the following final concentrations of reagents were used: Tm at 0.2 μg/ml (for qPCR), 2.5 μg/ml (for scratch wound assays), or 5 μg/ml (for immunoblot/microscopy); the IRE1i 4μ8c at 50 μM (MedChemExpress, #HY-19707), added 1 hour before infection; H 2 O 2 at 250 μM; catalase at 100 U/ml; and SOD (Sigma-Aldrich, #S5395) at 100 U/ml. ..

    Western Blot:

    Article Title: Enterococcus faecalis redox metabolism activates the unfolded protein response to impair wound healing
    Article Snippet: .. Unless otherwise specified, the following final concentrations of reagents were used: Tm at 0.2 μg/ml (for qPCR), 2.5 μg/ml (for scratch wound assays), or 5 μg/ml (for immunoblot/microscopy); the IRE1i 4μ8c at 50 μM (MedChemExpress, #HY-19707), added 1 hour before infection; H 2 O 2 at 250 μM; catalase at 100 U/ml; and SOD (Sigma-Aldrich, #S5395) at 100 U/ml. ..

    Infection:

    Article Title: Enterococcus faecalis redox metabolism activates the unfolded protein response to impair wound healing
    Article Snippet: .. Unless otherwise specified, the following final concentrations of reagents were used: Tm at 0.2 μg/ml (for qPCR), 2.5 μg/ml (for scratch wound assays), or 5 μg/ml (for immunoblot/microscopy); the IRE1i 4μ8c at 50 μM (MedChemExpress, #HY-19707), added 1 hour before infection; H 2 O 2 at 250 μM; catalase at 100 U/ml; and SOD (Sigma-Aldrich, #S5395) at 100 U/ml. ..



    Similar Products

    95
    MedChemExpress ire1i
    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor <t>(IRE1i)</t> 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Ire1i, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ire1i/4%CE%BC8C/pmc12810646-220-29-34
    Average 95 stars, based on 1 article reviews
    ire1i - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Millipore kira6 (5322810001, ire1i)
    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor <t>(IRE1i)</t> 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Kira6 (5322810001, Ire1i), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ire1i/kira6/10__7554_slash_elife__73913-373-16-31
    Average 90 stars, based on 1 article reviews
    kira6 (5322810001, ire1i) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore gsk- 2606414 (516535, ire1i)
    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor <t>(IRE1i)</t> 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Gsk 2606414 (516535, Ire1i), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ire1i/gsk++2606414++516535++ire1i+/10__7554_slash_elife__73913-373-12-31
    Average 90 stars, based on 1 article reviews
    gsk- 2606414 (516535, ire1i) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore gsk-2606414 (516535, ire1i)
    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor <t>(IRE1i)</t> 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Gsk 2606414 (516535, Ire1i), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ire1i/gsk++2606414++516535++ire1i+/pmc09090334-253-12-28
    Average 90 stars, based on 1 article reviews
    gsk-2606414 (516535, ire1i) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    Tocris synthesis n a isrib tocris 5284 doxycycline clontech nc0424034 ire1i
    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor <t>(IRE1i)</t> 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Synthesis N A Isrib Tocris 5284 Doxycycline Clontech Nc0424034 Ire1i, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ire1i/trans-ISRIB/pm30118681-151-217-220
    Average 95 stars, based on 1 article reviews
    synthesis n a isrib tocris 5284 doxycycline clontech nc0424034 ire1i - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Chembridge ire1α-specific inhibitor ire1i
    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor <t>(IRE1i)</t> 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Ire1α Specific Inhibitor Ire1i, supplied by Chembridge, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ire1i/ire1++specific+inhibitor+ire1i/pmc03700181-93-23-26
    Average 90 stars, based on 1 article reviews
    ire1α-specific inhibitor ire1i - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Chembridge ire1 -specific inhibitor ire1i
    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor <t>(IRE1i)</t> 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).
    Ire1 Specific Inhibitor Ire1i, supplied by Chembridge, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ire1i/ire1++specific+inhibitor+ire1i/10__1128_slash_jvi__00506___13-88-21-25
    Average 90 stars, based on 1 article reviews
    ire1 -specific inhibitor ire1i - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor (IRE1i) 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).

    Journal: Science Advances

    Article Title: Enterococcus faecalis redox metabolism activates the unfolded protein response to impair wound healing

    doi: 10.1126/sciadv.aeb5297

    Figure Lengend Snippet: ( A and B ) Gene expression of UPR markers ( Xbp1s , Chop , and Herpud1 ) in infected with E. faecalis at MOI of 800 (A) or 600 (B) or Tm treated NIH-3T3 mouse fibroblasts (A) or HaCaT human keratinocytes (B) ( n = 3). See Materials and Methods for multiplicities of infection (MOI) optimization description. ( C ) Gene expression of IRE1 downstream gene ( EDEM1 ) in cells treated as in (A) ( n = 3). ( D ) Quantitative analysis and representative immunoblots showing levels of XBP1s and BiP in HaCaT cells treated as in (A). ( E ) Scratch wound assay quantification for uninfected, infected, and Tm-treated cells (positive control). Shaded areas represent 1 SD for each condition ( n = 4 biological replicates). ( F ) Gene expression of XBP1s from HaCaT cells treated with the dimethyl sulfoxide (DMSO) control (open circles) or the IRE1 inhibitor (IRE1i) 4μ8c (closed circles) ( n = 3, one-way ANOVA, Dunnett’s test). ( G ) Scratch wound assay quantification for uninfected and infected cells treated with 0.5% DMSO control (open circles) or IRE1i (close circles) ( n = 4 biological replicates). Shaded areas represent 1 SD for each condition. Significance was determined using one-way ANOVA Dunnett’s test [(A) to (C)], two-way ANOVA Tukey’s test [(E) and (G)], or one-way ANOVA Tukey’s test (F) (* P < 0.05, ** P < 0.01, *** P < 0 0.001, and **** P < 0.0001).

    Article Snippet: Unless otherwise specified, the following final concentrations of reagents were used: Tm at 0.2 μg/ml (for qPCR), 2.5 μg/ml (for scratch wound assays), or 5 μg/ml (for immunoblot/microscopy); the IRE1i 4μ8c at 50 μM (MedChemExpress, #HY-19707), added 1 hour before infection; H 2 O 2 at 250 μM; catalase at 100 U/ml; and SOD (Sigma-Aldrich, #S5395) at 100 U/ml.

    Techniques: Gene Expression, Infection, Western Blot, Scratch Wound Assay Assay, Positive Control, Control

    ( A ) E. faecalis OG1RF Tn screen in which a library of 14,976 mutants was screened against an NIH-3T3 cell line expressing the Xbp1-mApple reporter system (3T3R). ( B ) Representative epifluorescence microscopy images of 3T3R under different conditions (uninfected, WT, and Tm-treated) at 21 hpi. Scale bar, 100 μm. ( C ) Diagram showing the pathways in which a subset of UPR-defective mutants (genes/proteins with red font) were identified. DHNA, 1,4-dihydroxy-2-naphthoic acid; GPP, geranyl diphosphate; HPP, heptaprenyl diphosphate; ETC, electron transport chain. ( D ) Validation of UPR-defective mutants with 3T3R ( n = 3). ( E ) UPR induction by WT and ΔT7SS in a 3T3(R) background ( n = 3). ( F and G ) Scratch wound assay quantification for HaCaT infected with (F) WT and ΔEET, which were also (G) treated with either 0.5% DMSO control (open circles) or IRE1i (close circles). WT data are identical to and replicated here for ease of comparison ( n = 4 biological replicates). The data underlying and (F) and (G) were generated in the same experimental sets and can therefore be directly compared against each other. Shaded areas represent 1 SD for each condition. ( H ) UPR induction at 24 hpi in HaCaT after treatment with 0.5% DMSO control (open circles) or IRE1i (closed circles) under uninfected, WT-infected, and ΔEET-infected conditions. Uninfected and WT-infected findings are identical to and replicated here for ease of comparison ( n = 3). Significance was determined using one-way ANOVA Dunnett’s test [(D) and (E)], two-way ANOVA Tukey’s test [(F) and (G)], or one-way ANOVA Tukey’s test (H) (*** P < 0 0.001 and **** P < 0.0001).

    Journal: Science Advances

    Article Title: Enterococcus faecalis redox metabolism activates the unfolded protein response to impair wound healing

    doi: 10.1126/sciadv.aeb5297

    Figure Lengend Snippet: ( A ) E. faecalis OG1RF Tn screen in which a library of 14,976 mutants was screened against an NIH-3T3 cell line expressing the Xbp1-mApple reporter system (3T3R). ( B ) Representative epifluorescence microscopy images of 3T3R under different conditions (uninfected, WT, and Tm-treated) at 21 hpi. Scale bar, 100 μm. ( C ) Diagram showing the pathways in which a subset of UPR-defective mutants (genes/proteins with red font) were identified. DHNA, 1,4-dihydroxy-2-naphthoic acid; GPP, geranyl diphosphate; HPP, heptaprenyl diphosphate; ETC, electron transport chain. ( D ) Validation of UPR-defective mutants with 3T3R ( n = 3). ( E ) UPR induction by WT and ΔT7SS in a 3T3(R) background ( n = 3). ( F and G ) Scratch wound assay quantification for HaCaT infected with (F) WT and ΔEET, which were also (G) treated with either 0.5% DMSO control (open circles) or IRE1i (close circles). WT data are identical to and replicated here for ease of comparison ( n = 4 biological replicates). The data underlying and (F) and (G) were generated in the same experimental sets and can therefore be directly compared against each other. Shaded areas represent 1 SD for each condition. ( H ) UPR induction at 24 hpi in HaCaT after treatment with 0.5% DMSO control (open circles) or IRE1i (closed circles) under uninfected, WT-infected, and ΔEET-infected conditions. Uninfected and WT-infected findings are identical to and replicated here for ease of comparison ( n = 3). Significance was determined using one-way ANOVA Dunnett’s test [(D) and (E)], two-way ANOVA Tukey’s test [(F) and (G)], or one-way ANOVA Tukey’s test (H) (*** P < 0 0.001 and **** P < 0.0001).

    Article Snippet: Unless otherwise specified, the following final concentrations of reagents were used: Tm at 0.2 μg/ml (for qPCR), 2.5 μg/ml (for scratch wound assays), or 5 μg/ml (for immunoblot/microscopy); the IRE1i 4μ8c at 50 μM (MedChemExpress, #HY-19707), added 1 hour before infection; H 2 O 2 at 250 μM; catalase at 100 U/ml; and SOD (Sigma-Aldrich, #S5395) at 100 U/ml.

    Techniques: Expressing, Epifluorescence Microscopy, Biomarker Discovery, Scratch Wound Assay Assay, Infection, Control, Comparison, Generated